Dorien de Jong
University Medical Center Utrecht(NL)University Medical Center Utrecht(NL)
Publications by Year
Research Areas
HIV Research and Treatment, HIV/AIDS drug development and treatment, HIV/AIDS Research and Interventions, SARS-CoV-2 and COVID-19 Research, CRISPR and Genetic Engineering
Most-Cited Works
- → Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy(1999)377 cited
- → A Novel Substrate-Based HIV-1 Protease Inhibitor Drug Resistance Mechanism(2007)167 cited
- → Lamivudine‐Resistant Human Immunodeficiency Virus Type 1 Variants (184V) Require Multiple Amino Acid Changes to Become Co‐Resistant to Zidovudine In Vivo(1997)107 cited
- → Transient Relapses (“Blips”) of Plasma HIV RNA Levels During HAART Are Associated With Drug Resistance(2001)91 cited
- → Ninety-Nine Is Not Enough: Molecular Characterization of Inhibitor-Resistant Human Immunodeficiency Virus Type 1 Protease Mutants with Insertions in the Flap Region(2008)48 cited
- → Persistence of HIV‐1 Variants with Multiple Protease Inhibitor (PI)–Resistance Mutations in the Absence of PI Therapy Can Be Explained by Compensatory Fixation(2007)42 cited
- → Failure of Treatment with First‐Line Lopinavir Boosted with Ritonavir Can Be Explained by Novel Resistance Pathways with Protease Mutation 76V(2009)34 cited
- → An Increase in Viral Replicative Capacity Drives the Evolution of Protease Inhibitor-Resistant Human Immunodeficiency Virus Type 1 in the Absence of Drugs(2006)30 cited
- → HIV-1 Can Persist in Aged Memory CD4+ T Lymphocytes With Minimal Signs of Evolution After 8.3 Years of Effective Highly Active Antiretroviral Therapy(2009)28 cited